Koch Disruptive Technologies and Norwest Venture Partners Lead Healthcare Investment Round
Koch Disruptive Technologies, along with other investors, contributed $8 million in a seed funding round for Neura Health. Neura Health is an innovative virtual neurology clinic that connects patients with top specialists in headache medicine. Their services include unlimited access to an online care team, personalized support, and biweekly care coaching sessions.
According to Forbes, Neura Health has plans to expand its solution beyond treating headaches and migraines. They aim to address other major neurological disease categories, such as sleep disorders and neurological pain. Co-founder and CEO Elizabeth Burstein expressed excitement about entering the enterprise market to provide care to a larger number of people who truly need and deserve it, drawing from her own personal experience.
The significance of this development lies in the prevalence and impact of migraines. The American Migraine Foundation reports that approximately 14% of the US population is affected by migraines, making it the second leading cause of global disability and the primary cause among young women. A study published in the peer-reviewed journal Headache revealed promising results for patients who joined Neura. After three months of membership, they experienced a median decrease of 73% in emergency room and urgent care visits, a median decline of 75% in headache frequency, and a median reduction of 67% in headache severity.
“Neura has built a proven solution to provide relief for individuals experiencing headache and migraine disorders,” KDT Managing Director Brendon Durkin told Forbes. “We’re excited to support Neura as it embarks on its next phase of growth – bringing its solution to more people via an expanded go-to-market strategy and making a significant impact for those living with major neurological conditions.”
Koch Disruptive Technologies (KDT) is partnering with Norwest Venture Partners to co-lead the investment round. Additionally, the round includes participation from pre-seed investors Pear VC and Next Play Ventures, as well as new investors Correlation Ventures and Plug and Play Ventures.
KDT has a strategic focus on healthcare investments, particularly in areas related to patient treatment and improving outcomes. In line with this focus, KDT has made recent investments in the healthcare sector. For instance, they have invested in Oshi Health, a company dedicated to revolutionizing virtual treatment for digestive issues. Another notable investment is ArteraAI, a company specializing in the development of multimodal artificial intelligence-based predictive and prognostic cancer tests. These investments highlight KDT's commitment to advancing healthcare through innovative solutions.
According to Forbes, Neura Health has plans to expand its solution beyond treating headaches and migraines. They aim to address other major neurological disease categories, such as sleep disorders and neurological pain. Co-founder and CEO Elizabeth Burstein expressed excitement about entering the enterprise market to provide care to a larger number of people who truly need and deserve it, drawing from her own personal experience.
The significance of this development lies in the prevalence and impact of migraines. The American Migraine Foundation reports that approximately 14% of the US population is affected by migraines, making it the second leading cause of global disability and the primary cause among young women. A study published in the peer-reviewed journal Headache revealed promising results for patients who joined Neura. After three months of membership, they experienced a median decrease of 73% in emergency room and urgent care visits, a median decline of 75% in headache frequency, and a median reduction of 67% in headache severity.
“Neura has built a proven solution to provide relief for individuals experiencing headache and migraine disorders,” KDT Managing Director Brendon Durkin told Forbes. “We’re excited to support Neura as it embarks on its next phase of growth – bringing its solution to more people via an expanded go-to-market strategy and making a significant impact for those living with major neurological conditions.”
Koch Disruptive Technologies (KDT) is partnering with Norwest Venture Partners to co-lead the investment round. Additionally, the round includes participation from pre-seed investors Pear VC and Next Play Ventures, as well as new investors Correlation Ventures and Plug and Play Ventures.
KDT has a strategic focus on healthcare investments, particularly in areas related to patient treatment and improving outcomes. In line with this focus, KDT has made recent investments in the healthcare sector. For instance, they have invested in Oshi Health, a company dedicated to revolutionizing virtual treatment for digestive issues. Another notable investment is ArteraAI, a company specializing in the development of multimodal artificial intelligence-based predictive and prognostic cancer tests. These investments highlight KDT's commitment to advancing healthcare through innovative solutions.
Companies